TRCT
SHPH icon

Tower Research Capital (TRC)’s Shuttle Pharmaceuticals SHPH Stock Holding History

Tower Research Capital (TRC)’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.15K Buy
464
+383
+473% +$5.19K ﹤0.01% 4360
2025
Q4 		$1.46K Sell
81
-21
-21% -$537 ﹤0.01% 4692
2025
Q3 		$3.6K Buy
102
+90
+750% +$3.37K ﹤0.01% 4480
2025
Q2 		$463 Sell
12
-2
-14% -$120 ﹤0.01% 5018
2025
Q1 		$1.32K Sell
14
-13
-48% -$2.11K ﹤0.01% 4736
2024
Q4 		$5.89K Buy
27
+12
+80% +$3.12K ﹤0.01% 4226
2024
Q3 		$5.13K Buy
+15
New +$9.2K ﹤0.01% 4324
2024
Q2 		– Hold
0
– – – 5423
2024
Q1 		– Hold
0
– – – 5653
2023
Q4 		– Hold
0
– – – 5777
2023
Q3 		– Hold
0
– – – 5769

Other funds holding SHPH

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $395M AUM 12.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Research Capital (TRC)'s SHPH Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Shuttle Pharmaceuticals (SHPH) stake by 473% in Q1 2026, buying an estimated $5.19K and bringing the position to 464 shares worth $3.15K. The position accounts for ﹤0.01% of the portfolio, ranked #4360.

Tower Research Capital (TRC) first reported a position in SHPH in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.89K in Q4 2024. 8 funds tracked by Wall St. Rank hold SHPH as of Q1 2026.

  • Tower Research Capital (TRC) held 464 shares of Shuttle Pharmaceuticals worth $3.15K as of Q1 2026.
  • Tower Research Capital (TRC) bought 383 Shuttle Pharmaceuticals shares in Q1 2026, an estimated $5.19K.
  • Shuttle Pharmaceuticals made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4360 holding.
  • Tower Research Capital (TRC) first reported a position in Shuttle Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Tower Research Capital (TRC)'s Shuttle Pharmaceuticals position peaked at $5.89K in Q4 2024.
  • 8 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.